Evolva Holding SA (SW:EVE) — Market Cap & Net Worth
Market Cap & Net Worth: Evolva Holding SA (EVE)
Evolva Holding SA (SW:EVE) has a market capitalization of $6.95 Million (CHF5.50 Million) as of August 4, 2026. Listed on the SW stock exchange, this Switzerland-based company holds position #27857 globally and #212 in its home market, demonstrating a -0.45% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Evolva Holding SA's stock price CHF2.19 by its total outstanding shares 7211552 (7.21 Million). See capital reinvestment ratio of Evolva Holding SA to understand how much of operating cash flow is reinvested back into capital assets.
Evolva Holding SA Market Cap History: 2015 to 2026
Evolva Holding SA's market capitalization history from 2015 to 2026. Data shows change from $2.20 Billion to $19.97 Million (-35.37% CAGR).
Evolva Holding SA Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Evolva Holding SA's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.70x
Evolva Holding SA's market cap is 0.70 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $1.39 Billion | $8.75 Million | -$35.97 Million | 159.40x | N/A |
| 2017 | $706.59 Million | $6.85 Million | -$38.98 Million | 103.20x | N/A |
| 2018 | $524.25 Million | $8.93 Million | -$29.21 Million | 58.69x | N/A |
| 2019 | $499.17 Million | $11.60 Million | -$21.64 Million | 43.05x | N/A |
| 2020 | $460.43 Million | $7.54 Million | -$29.87 Million | 61.06x | N/A |
| 2021 | $305.43 Million | $9.88 Million | -$41.27 Million | 30.92x | N/A |
| 2022 | $186.91 Million | $15.54 Million | -$43.37 Million | 12.03x | N/A |
| 2023 | $6.56 Million | $9.44 Million | -$105.23 Million | 0.70x | N/A |
Competitor Companies of EVE by Market Capitalization
Companies near Evolva Holding SA in the global market cap rankings as of August 4, 2026.
Key companies related to Evolva Holding SA by market ranking:
- Twenty One Capital, Inc. (NYSE:XXI): Ranked #7146 globally with a market cap of $1.48 Billion USD.
- Drugs Made In America Acquisition II Corp. Ordinary Shares (NASDAQ:DMII): Ranked #10802 globally with a market cap of $643.37 Million USD.
- Ares Acquisition Corporation II (NYSE:AACT): Ranked #11242 globally with a market cap of $587.05 Million USD.
- Churchill Capital Corp XI (NASDAQ:CCXI): Ranked #11391 globally with a market cap of $568.14 Million USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #7146 | Twenty One Capital, Inc. | NYSE:XXI | $1.48 Billion | $4.27 |
| #10802 | Drugs Made In America Acquisition II Corp. Ordinary Shares | NASDAQ:DMII | $643.37 Million | $10.11 |
| #11242 | Ares Acquisition Corporation II | NYSE:AACT | $587.05 Million | $9.49 |
| #11391 | Churchill Capital Corp XI | NASDAQ:CCXI | $568.14 Million | $13.86 |
Evolva Holding SA Historical Marketcap From 2015 to 2026
Between 2015 and today, Evolva Holding SA's market cap moved from $2.20 Billion to $ 19.97 Million, with a yearly change of -35.37%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CHF19.97 Million | +170.37% |
| 2025 | CHF7.39 Million | -10.00% |
| 2024 | CHF8.21 Million | +25.00% |
| 2023 | CHF6.56 Million | -96.49% |
| 2022 | CHF186.91 Million | -38.81% |
| 2021 | CHF305.43 Million | -33.66% |
| 2020 | CHF460.43 Million | -7.76% |
| 2019 | CHF499.17 Million | -4.78% |
| 2018 | CHF524.25 Million | -25.81% |
| 2017 | CHF706.59 Million | -49.33% |
| 2016 | CHF1.39 Billion | -36.52% |
| 2015 | CHF2.20 Billion | -- |
End of Day Market Cap According to Different Sources
On Aug 3rd, 2026 the market cap of Evolva Holding SA was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $6.95 Million USD |
| MoneyControl | $6.95 Million USD |
| MarketWatch | $6.95 Million USD |
| marketcap.company | $6.95 Million USD |
| Reuters | $6.95 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Evolva Holding SA
EvoNext Holdings SA is in the process of liquidation of its remaining assets. Previously, the company was engaged in discovery, research, development, and commercialization of nature-based ingredients for use in flavor and fragrances, health ingredients, health protection, and other sectors in Switzerland, the United States, and internationally. The company was formerly known as Evolva Holding SA… Read more